Offering regional and national programs, CIO (and CSO) events bring together some of the most respected names and thought leaders in information technology and security. Presented by CIOs and other senior level executives, these invitation-only programs offer timely topics and strong networking. Learn More »
Public Teleconferences
Join CIO Executive Council members and participate in the following live one-hour teleconferences:
* Transforming IT Teams
September 16
* Global CIOs: How to Lead on the World Stage
September 18
* Social Responsibility's Strategic Benefits
October 29
Apply today for a FREE subscription to CIO Magazine!
May 11, 2007 — CSO —
For well over two years now, every single bottle of OxyContin that's bound for either Wal-Mart, the world's largest retailer, or H.D. Smith, a midsize drug wholesaler, has been slapped with a special label that's hailed as the solution to the world's counterfeit drug problem.
Hidden inside each ordinary-looking label is a Radio-Frequency ID (RFID) tag that is supposed to allow Purdue Pharma, manufacturer of the controversial painkiller, to track the drug's progress throughout the supply chain-regardless of how many pills are poured into how many bottles and stacked into how many cardboard boxes whizzing by on a conveyor belt. The idea is that distributors could quickly scan all their bottles of OxyContin, learn the complete provenance, or "pedigree," of each one, and reject any that could not be traced back to Purdue.
"It's efficient, it's accurate, it does what we want it to do from a security perspective, and it doesn't bog down the distribution system," says Aaron Graham, VP and CSO of Purdue Pharma, adding that the infrastructure investment for the pilot project was $2 million and each tag costs between 30 and 50 cents.
If what Graham is saying sounds familiar, right down to the numbers he cites, that's because he's been saying the same thing for years. Yet even now, he can offer remarkably little detail about how the system has prevented counterfeit OxyContin from being sold. Purdue, after all, has never had a problem with counterfeit OxyContin. What the company has had instead is a problem with stolen and diverted OxyContin, along with pressure from the government to get better control over a highly addictive drug that has received much more media attention for its abuse than its use.
Indeed, Graham acknowledges that the main security advantage of Purdue's RFID system is that investigators can scan a seized bottle or box of OxyContin and pinpoint exactly where it came from. To really stop counterfeit drugs, Graham says, would require a central information clearinghouse where every distributor and pharmacy checked and validated the pedigree of every drug-a far more complex task than tracking one type of drug going to two different outlets, as Purdue is doing.
Just the basics, please. Sometimes we all need a refresher or we need to make sure our team and our colleagues are all on the same page.
Over 25 tutorials on everything from business intelligence to virtualization.